Pluchea indica — Hermetica Encyclopedia
Herb · Pacific Islands

Pluchea indica

Preliminary EvidenceCompound

Hermetica Superfood Encyclopedia

The Short Answer

Pluchea indica aerial parts contain novel thiophene derivatives (pluthiophenols 1–4), esculetin, dihydroxybenzaldehydes, and lignans that suppress LPS-induced nitric oxide production in macrophages by inhibiting inducible nitric oxide synthase (iNOS) pathways. In vitro studies demonstrate that select isolates at 40 µM significantly inhibit NO production in RAW 264.7 macrophages, positioning the plant as a candidate anti-inflammatory and digestive remedy, though no human clinical trials have yet confirmed these effects.

PubMed Studies
7
Validated Benefits
Synergy Pairings
At a Glance
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary KeywordPluchea indica benefits
Hypomeia indica close-up macro showing natural texture and detail — rich in anti-inflammatory, digestive, antioxidant
Pluchea indica — botanical close-up

Health Benefits

**Anti-inflammatory Activity**
Novel thiophene compounds (pluthiophenols 1 and 2) and esculetin isolated from aerial parts inhibit LPS-stimulated nitric oxide production in macrophages at 40 µM, suggesting suppression of iNOS-mediated inflammatory cascades.
**Digestive Tract Support**
Traditional Polynesian and Hawaiian use centers on relieving gastrointestinal complaints including constipation and indigestion, with aerial parts prepared as decoctions acting as a gentle purge by stimulating intestinal motility.
**Antioxidant Potential**
Phenolic constituents including esculetin (a coumarin), dihydroxybenzaldehydes, and hydroxyphenyl propanone derivatives contribute electron-donating capacity that may neutralize reactive oxygen species in gut epithelium.
**Antimicrobial Properties**
Thiophene-containing natural products are well-characterized for membrane-disrupting antimicrobial activity; the novel pluthiophenol scaffold in P. indica suggests potential against enteric pathogens, consistent with its traditional use in gastrointestinal purging.
**Hepatoprotective Potential**
Esculetin and lignan constituents identified in P. indica extracts are structurally related to compounds demonstrated in other Asteraceae species to attenuate hepatic oxidative stress and support liver detoxification enzyme activity.
**Wound Healing and Topical Use**
Leaves of related Pluchea species are applied topically across Pacific traditions to wounds and skin infections, with phenolic and coumarin constituents providing a plausible biochemical rationale through anti-inflammatory and antimicrobial mechanisms.
**Immunomodulatory Effects**
Multiple isolates (compounds 1, 2, 10, 13, 18, 23) significantly modulate macrophage inflammatory responses in vitro, suggesting the whole-plant extract may broadly tune innate immune activity rather than acting through a single mechanism.

Origin & History

Hypomeia indica growing in Southeast Asia — natural habitat
Natural habitat

Pluchea indica (family Asteraceae), the plant most consistent with the traditional Pacific Islands medicinal plant referred to as 'Hypomeia indica,' is native to coastal and tropical regions spanning South and Southeast Asia, extending into Pacific Island territories including Hawaii and Polynesia. It thrives in mangrove margins, sandy coastal soils, and disturbed tropical lowlands, tolerating high salinity and humid climates. The plant has been cultivated and gathered from the wild across Polynesia and Hawaii for generations, where aerial parts—leaves, stems, and flowering tops—are harvested for medicinal preparations.

Across Polynesia and in Hawaiian herbal traditions, the plant recognized locally as 'Hypomeia indica' (most consistent botanically with Pluchea indica or a closely related coastal Asteraceae) has been employed by traditional healers (kahunas in Hawaii) as a purgative and remedy for gastrointestinal disorders including constipation, bloating, and intestinal parasites. Leaves were gathered from coastal scrublands, prepared as hot-water infusions or decoctions, and administered in measured doses to stimulate bowel evacuation and relieve abdominal discomfort, reflecting an empirical understanding of the plant's laxative and carminative properties. In broader Southeast Asian ethnomedicine, Pluchea indica leaves are documented in Thai, Indonesian, and Filipino traditional systems as treatments for rheumatism, cough, and skin diseases, suggesting a pan-tropical cultural recognition of the plant's medicinal utility that predates formal phytochemistry by centuries. The plant's prevalence in coastal Pacific environments made it a reliably accessible medicinal resource for island communities, and its continued recognition in contemporary Hawaiian ethnobotanical surveys indicates living transmission of this knowledge.Traditional Medicine

Scientific Research

The available scientific literature on Pluchea indica is limited predominantly to in vitro phytochemical isolation studies; a 70% ethanol-water extraction of aerial parts yielded 4 novel thiophenes and 25 known compounds, with anti-inflammatory activity assessed by NO inhibition in LPS-stimulated RAW 264.7 macrophages (n=4 replicates per compound, dexamethasone 1 µg/mL as positive control), representing preliminary preclinical evidence without IC₅₀ quantification. No peer-reviewed human clinical trials have been published for Pluchea indica or the named 'Hypomeia indica' variant; evidence for traditional Pacific Island uses rests entirely on ethnobotanical surveys and oral tradition rather than controlled experimentation. The body of in vitro work, while mechanistically suggestive, lacks dose-response characterization, pharmacokinetic data, and in vivo validation in animal models, precluding any reliable translation of findings to human supplementation contexts. This represents a significant evidence gap; researchers and clinicians should treat all proposed health benefits as hypothesis-generating rather than clinically established.

Preparation & Dosage

Hypomeia indica prepared as liquid extract — pairs with In traditional Polynesian medicine, purgative plant preparations are commonly combined with demulcent herbs such as taro root (Colocasia esculenta) mucilage to buffer gastrointestinal irritation from laxative compounds, which may reduce cramping while preserving the bowel-clearing effect of P. indica constituents. The esculetin content suggests potential synergy with other COX/LOX-inhibiting botanicals such as turmeric
Traditional preparation
**Traditional Decoction (Polynesian/Hawaiian)**
10–15 g dry weight) per cup of water, consumed once daily for digestive complaints—no validated clinical dose established
Fresh or dried aerial parts (leaves and stems) simmered in water for 15–20 minutes; typical preparation involves a small handful (~.
**70% Ethanol-Water Extract (Research Grade)**
Used in phytochemical isolation studies; in vitro testing employed 100 µg/mL of crude extract on macrophage cultures—not a dosage translatable to human supplementation without further pharmacokinetic study.
**Isolated Compound Concentration (In Vitro Reference)**
Active thiophene isolates tested at 40 µM; no human equivalent dose has been calculated due to absent bioavailability data.
**Standardization**
No commercial standardized extract exists; no marker compound has been designated for quality control in supplement manufacturing.
**Timing Notes**
Traditional use is typically acute (1–3 days) for digestive purging; no long-term dosing regimens have been documented or studied.
**Caution**
In the absence of clinical dose-finding studies, no safe or effective dose range can be recommended; use should follow guidance from practitioners familiar with Pacific Islands botanical medicine.

Nutritional Profile

Pluchea indica aerial parts contain a complex array of secondary metabolites rather than notable macronutrient density; leaves provide modest dietary fiber, trace chlorophyll, and flavonoid pigments as primary nutritional constituents. Key phytochemicals identified by isolation include thiophene glycosides and aglycones (pluthiophenols 1–4; isolation yield up to 69.6 mg per extraction batch from aerial parts), dihydroxybenzaldehydes (compound 5 at 44.2 mg isolation yield; compound 7 at 9.1 mg), the coumarin esculetin (12.0 mg isolation yield), lignans (11.9 mg), and sesquiterpene alcohols including caryolane-1,9β-diol (13.3 mg). Hydroxyphenyl propanone derivatives (2,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)-propan-1-one; 6.6 mg) add to the phenylpropanoid profile. Quantitative data on macronutrients (protein, carbohydrate, fat content) and micronutrients (vitamins, minerals) are not available in published literature for this species; bioavailability of the phenolic compounds is expected to be moderate and influenced by gut microbiota metabolism of coumarin and lignan precursors.

How It Works

Mechanism of Action

Key bioactive isolates from Pluchea indica, particularly the thiophene derivatives pluthiophenol-1 and pluthiophenol-4″-acetate (compound 2, molecular formula C₁₅H₁₂O₃S), along with the coumarin esculetin (compound 13) and caryolane-1,9β-diol (compound 19), inhibit LPS-induced nitric oxide production in RAW 264.7 macrophages when applied at 40 µM prior to LPS stimulation, implicating suppression of the iNOS/NF-κB inflammatory axis as a primary mechanism. The thiophene ring system, hydroxyl substituents, and alkynyl moiety (confirmed by IR absorption at 2222 cm⁻¹) are structural features associated with electrophilic modulation of cysteine-containing signaling proteins, potentially including IκB kinase subunits that gate NF-κB nuclear translocation. Esculetin independently inhibits cyclooxygenase (COX) and lipoxygenase (LOX) enzymes in other biological systems, providing an additional arachidonic acid pathway target that may synergize with the thiophene-mediated iNOS suppression. The lignans (compound 17) may contribute via interference with topoisomerase or nuclear receptor pathways, though gene expression-level confirmatory data for P. indica specifically remain unpublished.

Clinical Evidence

No human clinical trials have been conducted on Pluchea indica or the Pacific Islands plant referred to as Hypomeia indica; the entire clinical evidence base consists of in vitro cell-culture experiments. These studies demonstrate statistically significant inhibition of nitric oxide production by select isolates at 40 µM in macrophage models, but effect sizes (e.g., IC₅₀ values, percent inhibition relative to control) were not fully reported in available publications, limiting interpretation. Traditional use in Hawaiian and Polynesian medicine for digestive purging and gastrointestinal ailments represents the longest-standing 'clinical' observation, but this anecdotal record has not been subjected to systematic ethnopharmacological review with adequate patient documentation. Confidence in any clinical outcome for this ingredient is very low; prospective cohort studies or randomized controlled trials are entirely absent.

Safety & Interactions

No formal toxicological studies, adverse event reports, or drug interaction evaluations have been published for Pluchea indica or the plant identified as Hypomeia indica in Pacific Islands traditions; the safety profile is therefore characterized by a near-complete absence of evidence rather than established safety. The traditional purgative use implies potential for gastrointestinal cramping, diarrhea, or electrolyte disturbance with excessive consumption, consistent with risks associated with other herbal laxatives; use should be avoided in individuals with inflammatory bowel disease, intestinal obstruction, or electrolyte imbalances. Given the presence of coumarin derivatives (esculetin), a theoretical interaction with anticoagulant medications (warfarin, direct oral anticoagulants) should be considered, as coumarin-class compounds can potentiate anticoagulant effects—though direct evidence for this interaction with P. indica specifically is absent. Pregnant and lactating individuals should avoid use entirely given the purgative properties and complete absence of reproductive safety data; no maximum safe dose has been established for any population.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Pluchea indica Less.Hypomeia indicaIndian camphorweedSourbushMarsh fleabane Pacific

Frequently Asked Questions

What is Hypomeia indica used for in Hawaiian traditional medicine?
In Hawaiian and broader Polynesian traditional medicine, Hypomeia indica (most likely Pluchea indica) is used primarily as a purgative and digestive remedy, with leaf decoctions prepared to relieve constipation, bloating, and intestinal discomfort. Practitioners historically administered the hot-water infusion of aerial parts in acute short-course regimens of 1–3 days, reflecting empirical recognition of its laxative and gastrointestinal-stimulating properties. No clinical trials have validated these traditional applications.
What are the active compounds in Pluchea indica?
Phytochemical isolation from a 70% ethanol-water extract of Pluchea indica aerial parts identified 4 novel thiophene derivatives called pluthiophenols (compounds 1–4), plus 25 known compounds including dihydroxybenzaldehydes, the coumarin esculetin, lignans, and the sesquiterpene caryolane-1,9β-diol. The thiophene compound pluthiophenol-4″-acetate (C₁₅H₁₂O₃S, m/z 273.05781) is among the most structurally characterized isolates and contributes to the plant's in vitro anti-inflammatory activity.
Is there scientific evidence that Pluchea indica reduces inflammation?
In vitro evidence shows that compounds 1, 2, 10, 13, 18, and 23 from Pluchea indica significantly inhibit LPS-induced nitric oxide production in RAW 264.7 macrophages when tested at 40 µM, with dexamethasone used as a positive control, suggesting iNOS pathway suppression. However, no animal studies or human clinical trials have confirmed this effect in living systems, and IC₅₀ values were not reported, making it impossible to gauge potency relative to established anti-inflammatory agents.
What is the safe dosage of Hypomeia indica or Pluchea indica supplements?
No clinically validated safe or effective dosage has been established for Pluchea indica or Hypomeia indica in any human population; no pharmacokinetic or toxicological studies have been published. Traditional Hawaiian use involves a small handful (~10–15 g) of dried aerial parts as a once-daily decoction for short-term digestive complaints, but this dose has never been confirmed as safe or effective through controlled research. Individuals should consult a qualified healthcare provider before use, particularly those on anticoagulant medications or with gastrointestinal disorders.
Is Pluchea indica the same plant as Hypomeia indica?
The name 'Hypomeia indica' does not correspond to a recognized botanical taxon in major plant databases; the closest scientifically validated match is Pluchea indica Less. (family Asteraceae), a coastal tropical herb distributed across South and Southeast Asia into Pacific Island territories including Hawaii. It is likely that 'Hypomeia indica' represents a regional vernacular misattribution or orthographic variant used in Pacific Islands ethnobotanical records, and available phytochemical and pharmacological data for this plant derives from studies conducted on P. indica.
Does Pluchea indica interact with anti-inflammatory medications like NSAIDs?
While Pluchea indica contains compounds that suppress inflammatory pathways (specifically iNOS-mediated cascades), there is limited clinical data on concurrent use with NSAIDs or other anti-inflammatory drugs. Because both may influence inflammatory signaling, consulting a healthcare provider before combining them is advisable to avoid potential additive or synergistic effects. Current evidence is insufficient to establish definitive safety guidelines for co-administration.
What is the most effective form of Pluchea indica for digestive support—fresh plant, dried herb, or extract?
Traditional Polynesian and Hawaiian preparations typically used dried aerial parts of Pluchea indica for gastrointestinal complaints, suggesting this form has established cultural efficacy. Standardized extracts containing the active thiophene compounds (pluthiophenols) and esculetin may offer more consistent dosing, though direct comparative clinical studies between forms are lacking. The optimal form likely depends on bioavailability needs and intended use, warranting further research to establish relative effectiveness.
Is Pluchea indica safe for children or during pregnancy?
There is no clinical safety data establishing the use of Pluchea indica supplements in children or pregnant women, despite its traditional use in Polynesian cultures. Given the presence of bioactive compounds (thiophenes and esculetin) with documented pharmacological activity, precautionary avoidance during pregnancy and in pediatric populations is recommended until adequate safety studies are conducted. Healthcare providers should be consulted before use in these vulnerable populations.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.